Smuggling on the Nanoscale—Fusogenic Liposomes Enable Efficient RNA-Transfer with Negligible Immune Response In Vitro and In Vivo

Marco Hoffmann, S. Gerlach, Masanari Takamiya, Samar Tarazi, Nils Hersch, Ágnes Csiszár, Ronald Springer, Georg Dreissen, Hanno Scharr, Sepand Rastegar, Tanja Beil, Uwe Strähle, Rudolf Merkel, Bernd HoffmannPharmaceutics 2023 · DOI

TL;DR

This paper introduces a novel method for delivering RNA into cells using fusogenic liposomes, which bypasses cellular defense mechanisms that typically trigger inflammatory responses. This approach demonstrates significantly higher efficiency and biocompatibility compared to traditional lipofection methods, both in cell cultures and in living organisms, paving the way for safer and more effective RNA-based therapies.

What Problem Does This Paper Address?

Delivering nucleic acids, particularly RNA, into cells for therapeutic or research purposes is a major hurdle in modern medicine and biology. While viral methods are highly efficient, they come with significant safety concerns. Conventional non-viral methods like lipofection are safer but suffer from low efficiency and, critically, can provoke unwanted inflammatory responses. This inflammation is often triggered by the cell's innate immune system recognizing the nucleic acids as foreign, particularly when they enter through endosomal pathways. The challenge, therefore, is to find a delivery system that is both highly efficient and avoids activating these immune defenses, especially for applications like treating brain injuries or genetic diseases where inflammation is detrimental.

Methods

The core of this research lies in comparing two RNA delivery systems: a standard lipofection reagent (Lipofectamine® 2000) and a novel approach using commercially available fusogenic liposomes (Fuse-It-mRNA). The key innovation is the fusogenic nature of these liposomes, which are designed to directly fuse with the cell's plasma membrane, releasing their RNA cargo directly into the cytoplasm. This bypasses the endosomal pathway, a common route for lipofection, which is heavily monitored by the cell's immune sensors.

The researchers employed a multi-pronged approach:

  • In Vitro Studies: They tested the systems on various cell lines (PC-12, CHO-K1, nHEK) and primary rat cortical neurons. They assessed RNA transfer efficiency (eGFP expression via fluorescence microscopy and flow cytometry), cell viability (LIVE/DEAD assay), and inflammatory responses (qRT-PCR for IL-6 and TNF-α cytokine mRNA). They also investigated the role of endocytosis by using an inhibitor (β-MCD) and by comparing protocols with and without endosomal blocking.
  • In Vivo Studies: The efficacy and safety of the fusogenic liposomes were further validated in adult zebrafish brains and zebrafish embryos. This involved microinjection of RNA-loaded liposomes and subsequent analysis of GFP expression and inflammatory markers in tissue samples.
  • Neuronal Network Functionality: To assess biocompatibility at a functional level, they used live cell calcium imaging to monitor the synchronized activity of primary cortical neuronal networks after RNA delivery.

Datasets

The study utilized established cell lines (Chinese hamster ovary K1, pheochromocytoma-12, primary neonatal human epidermal keratinocytes) and primary rat embryonic cortical neurons. For in vivo studies, wildtype zebrafish (Danio rerio) were used. No new benchmark datasets were introduced; rather, the study focused on evaluating existing delivery systems against a novel one using standard biological assays and model organisms.

Key Insights and Ideas

  • Bypassing the Endosome is Key: The most significant finding is that fusogenic liposomes, by directly fusing with the cell membrane and releasing RNA into the cytoplasm, effectively circumvent the endosomal pathway. This bypass is crucial because endosomes are rich in pattern recognition receptors (PRRs) that detect foreign nucleic acids and trigger inflammatory responses.
  • Inflammation Abolishment: This bypass mechanism directly leads to a near-complete abolishment of inflammatory cytokine responses (like IL-6 and TNF-α) that are commonly observed with lipofection. This is a major advantage for therapeutic applications where inflammation can be detrimental.
  • Efficiency and Biocompatibility Go Hand-in-Hand: Unlike traditional methods where high efficiency often comes at the cost of increased cytotoxicity, fusogenic liposomes achieve both high RNA transfer efficiency and excellent biocompatibility, meaning they are less toxic to cells and tissues.
  • In Vivo Efficacy Confirmed: The benefits observed in vitro were replicated in living organisms. Fusogenic liposomes demonstrated efficient RNA transfer in adult zebrafish brains and embryos, with minimal signs of inflammation, whereas lipofection led to significant inflammatory responses.
  • Functional Network Preservation: In primary neuronal cultures, lipofection severely impaired the functional communication within neuronal networks, while fusogenic liposomes had a much milder impact, preserving network activity.

Key Results

  • In Vitro: Fusogenic liposomes achieved comparable or even superior RNA transfer efficiency to lipofection, but with significantly reduced cell death (e.g., >80% fewer dead cells in nHEK cells compared to lipofection) and drastically lower pro-inflammatory cytokine (IL-6) expression (e.g., ~400-fold lower in nHEK cells).
  • In Vivo (Zebrafish Brain): Fusion-based delivery resulted in widespread GFP expression in 35% of telencephalon cells, whereas lipofection yielded only scattered expression in 5.3% of cells. Crucially, lipofection induced strong inflammatory responses (IL-6 and TNF-α), even exceeding those from LPS injection, while fusion showed only marginally increased responses.
  • In Vivo (Zebrafish Embryo): Fusogenic liposomes led to broad GFP expression in various embryonic tissues, while lipofection resulted in expression primarily localized to the yolk, with no significant teratological effects observed for either method.

Limitations and Future Work

  • Mechanism of Action: While the study strongly suggests the endosomal bypass is the primary reason for reduced inflammation, the precise fate and interaction of fusogenic liposome components with the cell membrane and cytoplasm warrant further investigation.
  • Optimization: Although Fuse-It-mRNA is commercially available, the paper mentions that the specific formulation and neutralization buffer were developed to optimize fusion. Further optimization of these components could potentially enhance efficiency even further.
  • Long-Term Effects: While short-term biocompatibility and efficacy are demonstrated, long-term effects of sustained RNA expression or repeated administration of fusogenic liposomes in vivo would be valuable to explore.
  • Broader Applications: The study focused on mRNA transfer. Future work could explore the applicability of fusogenic liposomes for delivering other nucleic acids like siRNA, shRNA, or even DNA.
  • Penetration in Complex Tissues: The paper notes that it remains an open question how fusion-mediated transfer can reach deeper layers of complex tissues, although some evidence suggests potential vascularization. Further studies are needed to understand and potentially improve penetration in challenging anatomical regions.

Summary updated

Abstract

The efficient and biocompatible transfer of nucleic acids into mammalian cells for research applications or medical purposes is a long-standing, challenging task. Viral transduction is the most efficient transfer system, but often entails high safety levels for research and potential health impairments for patients in medical applications. Lipo- or polyplexes are commonly used transfer systems but result in comparably low transfer efficiencies. Moreover, inflammatory responses caused by cytotoxic side effects were reported for these transfer methods. Often accountable for these effects are various recognition mechanisms for transferred nucleic acids. Using commercially available fusogenic liposomes (Fuse-It-mRNA), we established highly efficient and fully biocompatible transfer of RNA molecules for in vitro as well as in vivo applications. We demonstrated bypassing of endosomal uptake routes and, therefore, of pattern recognition receptors that recognize nucleic acids with high efficiency. This may underlie the observed almost complete abolishment of inflammatory cytokine responses. RNA transfer experiments into zebrafish embryos and adult animals fully confirmed the functional mechanism and the wide range of applications from single cells to organisms.
BibTeX
@inproceedings{hoffmann2023smuggling,
  author = {Marco Hoffmann and S. Gerlach and Masanari Takamiya and Samar Tarazi and Nils Hersch and Ágnes Csiszár and Ronald Springer and Georg Dreissen and Hanno Scharr and Sepand Rastegar and Tanja Beil and Uwe Strähle and Rudolf Merkel and Bernd Hoffmann},
  title = {{Smuggling on the Nanoscale—Fusogenic Liposomes Enable Efficient RNA-Transfer with Negligible Immune Response In Vitro and In Vivo}},
  booktitle = {Pharmaceutics},
  year = {2023},
  doi = {10.3390/pharmaceutics15041210},
}
Figure